Zebutinib Combined With Immunochemotherapy in the Treat of Newly Treated CLL Patients Without 17p-/TP53 Mutation
Clinical trial NCT04980859 · UNKNOWN
Trial details
- NCT number
- NCT04980859
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2025-09-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.